Riskpilot← Back to searchSign inGet full accessVIROGATES A/S
A/SActiveCVR 25734033Banevænget 13, 1.Wholesale of pharmaceutical and medical goods · NACE 4646Est. 200011 employeeswww.virogates.com
Revenue 2025
DKK 5,3M
+8% vs 2024
EBITDA margin
-197.3%
+28% vs 2024
Equity ratio
63.4%
Financial strength
Net profit 2025
DKK -10,4M
+28% vs 2024
| Revenue | DKK 5,3M | +8% |
| EBITDA | DKK -10,5M | +28% |
| Net profit | DKK -10,4M | +28% |
| Total assets | DKK 30,6M | +73% |
| Equity | DKK 19,4M | +80% |
| Employees | 11 | — |
Legal name
VIROGATES A/S
CVR number
25734033
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. november 2000
Share capital
DKK 9.284.476
Employees
11 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med bestyrelsens formand eller næstformand eller i forening med to bestyrelsesmedlemmer eller af formanden i forening med et bestyrelsesmedlem.
Company purpose
Selskabets formål er at drive virksomhed med udvikling, markedsføring og salg og distribution af produkter og serviceydelser inden for medicinsk diagnosticering og prognosticering og det farmaceutiske marked.
Address
Banevænget 13, 1.
Phone
+4521131336
Email
info@virogates.com
Website
www.virogates.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 933 | 981 | 3.104 | 3.592 | 3.686 | 2.441 | 3.315 | 3.582 | 5.354 | 7.656 | 10.151 | 5.582 | 4.897 | 5.307 |
| Staff expenses | -4.724 | -4.281 | -4.076 | -3.563 | -3.335 | -3.308 | -5.858 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -8.838 | -8.793 | -7.244 | -5.255 | -6.838 | -7.573 | -17.977 | -19.607 | -19.500 | -18.573 | -10.670 | -12.565 | -14.560 | -10.472 |
| Depreciation & amort. | -330 | -621 | 83 | 100 | 99 | -118 | -125 | -116 | -229 | -217 | -175 | -0 | -0 | -0 |
| EBIT | -9.168 | -9.413 | -7.326 | -5.354 | -6.937 | -7.691 | -18.102 | -19.723 | -19.729 | -18.790 | -10.845 | -12.565 | -14.560 | -10.472 |
| Net financials | -7 | -319 | -206 | 22 | 39 | -6 | -814 | -286 | -253 | -175 | -30 | -525 | -620 | -756 |
| Profit before tax | -9.175 | -9.732 | -7.532 | -5.332 | -6.898 | -7.697 | -18.916 | -20.009 | -19.982 | -18.965 | -10.876 | -13.090 | -15.180 | -11.229 |
| Tax | -1.250 | 4.489 | -1.807 | -1.262 | -1.495 | -1.710 | -1.930 | -1.212 | -1.246 | -1.302 | -1.230 | -994 | -835 | -832 |
| Net profit | -7.925 | -14.221 | -5.726 | -4.070 | -5.403 | -5.987 | -16.986 | -18.797 | -18.736 | -17.663 | -9.646 | -12.096 | -14.345 | -10.397 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 11.127 | 3.849 | 10.506 | 17.412 | 11.997 | 4.978 | 63.424 | 45.157 | 38.246 | 20.229 | 17.539 | 24.555 | 17.660 | 30.589 |
| Equity | 8.906 | -5.315 | 7.457 | 14.387 | 8.984 | 2.997 | 61.012 | 42.215 | 31.314 | 16.426 | 16.088 | 17.007 | 10.795 | 19.403 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.020 | 0 | 0 | 5.300 | 4.273 | 3.330 |
| Short-term debt | 2.221 | 9.164 | 3.049 | 3.025 | 3.013 | 1.980 | 2.412 | 2.942 | 5.912 | 3.803 | 1.451 | 2.248 | 2.591 | 7.856 |
| Total debt | 2.221 | 9.164 | 3.049 | 3.025 | 3.013 | 1.980 | 2.412 | 2.942 | 6.932 | 3.803 | 1.451 | 7.548 | 6.864 | 11.186 |
EBITDA margin
-197.3%
This company
15.8%
Market median
-1349% vs market
20122025
Equity ratio
63.4%
This company
38.2%
Market median
+66% vs market
20122025
Return on equity
-53.6%
This company
18.4%
Market median
-391% vs market
20122025
Net profit margin
-195.9%
This company
8.1%
Market median
-2519% vs market
20122025
Asset turnover
0.17×
This company
1.12×
Market median
-85% vs market
20122025
Debt / equity
0.58×
This company
0.62×
Market median
+6% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KB Audit | Audit | 2000 | — | — |
JG Chief Executive Officer | Chief Executive Officer | 2001 | — | — |
VC Management | Management | 2000 | — | — |
BS Management | Management | 2007 | — | — |
JO Chief Executive Officer | Chief Executive Officer | 2011 | — | — |
IR Chief Executive Officer | Chief Executive Officer | 2003 | — | — |
JE Management | Management | 2001 | — | — |
MB Management | Management | 2009 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2001 | — | — | |
| Board of Directors | 2022 | — | — | |
| Deputy Chairman | 2009 | — | — | |
| Board of Directors | 2001 | — | — | |
| Deputy Chairman | 2007 | — | — | |
| Deputy Chairman | 2011 | — | — | |
| Board of Directors | 2016 | — | — | |
| Board of Directors | 2015 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2008 | — | — | |
| Board of Directors | 2013 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2009 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 25.0% | 25.0% | 2025 | |
N. P. LOUIS-HANSEN ApS | Company | 25.0% | 25.0% | 2025 |
| Individual | 20.0% | 20.0% | 2024 | |
Ginnerup Capital ApS | Company | 10.0% | 10.0% | 2025 |
4AM ApS | Company | 10.0% | 10.0% | 2014 |
JEO HOLDING ApS | Company | 5.0% | 5.0% | 2014 |
THE WAY FORWARD ApS | Company | 5.0% | 5.0% | 2014 |
Hargreave Holding ApS | Company | 5.0% | 5.0% | 2023 |
SCANAFRIC ApS | Company | 5.0% | 5.0% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ginnerup Capital ApS
VIROGATES A/S Board members of VIROGATES A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl-Alfred Brylle | Audit | 0 companies |
| Jesper Gilg | Chief Executive Officer | 0 companies |
| Victor Christoffersen | Management | 0 companies |
| Betina Susanna Thorball | Management | 0 companies |
| Jakob Ole Knudsen | Chief Executive Officer | 0 companies |
| Ian Rodney Laquian | Chief Executive Officer | 0 companies |
| Jesper Eugen-Olsen | Management | 0 companies |
| May Britt Dyvelkov | Management | 0 companies |
| Jørgen Axel Thorball | Chairman | 0 companies |
| Valerie Soulier | Board of Directors | 0 companies |
| Karin Verland | Deputy Chairman | 0 companies |
| Peter Benson | Board of Directors | 0 companies |
| Mads Krarup Kjær | Deputy Chairman | 0 companies |
| Jan-Ole Hansen | Deputy Chairman | 0 companies |
| Lars Krogsgaard | Board of Directors | 0 companies |
| Bernd Peter Uder | Board of Directors | 0 companies |
| Henrik Stender | Board of Directors | 0 companies |
| Niels Lysholm Engelhard | Board of Directors | 0 companies |
| John Joseph Reddington | Board of Directors | 0 companies |
| Patrik Olof Dahlén | Chairman | 0 companies |
| Poul Kirketerp Andersson | Board of Directors | 0 companies |
| Lars Kongsbak | Board of Directors | 0 companies |